Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Global Insomnia Market to Grow at 6.6% CAGR and Reach Nearly US$ 4 Bn in Revenues

Press release Description

Albany, New York, April 4, 2018: A new insightful study titled “Insomnia Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2026” has recently been added to the database of Market Research Reports Search Engine (MRRSE). The global insomnia market is likely to grow at 6.6% CAGR during the assessment period 2017-2026 and reach a valuation of nearly US$ 4 Bn by 2026.

The report studies the competitive landscape in the insomnia market in detail, and offers a holistic analysis on the business and product strategies of key players. A lucid analysis on the qualitative and quantitative factors impacting market growth has been included for the perusal of readers. The demand supply equations and pipeline reviews of insomnia drugs have also been discussed in detail in the report.

According to the study, the demand for effective insomnia drugs is rising on account of increase in the prevalence of sleep disorders. The hectic lifestyle, urbanization, work stress, smartphone addition, and alcohol dependency have contributed to reduce the quality of life in a significant percentage of population around the globe. The demand for effective medication that does not lead to dependency is growing, and these factors are likely to provide an impetus to growth of the market during the assessment period.

According to the report, the global insomnia market is in a transition, with focus shifting from medications to effective use of technology. For a long period of time, insomnia treatment has remained restricted to antidepressants, which have a high dependency and addiction risk. However, innovation in technology have meant that a number of sleep inducing and sleep monitoring devices have been launched in the market, which can offer an effective, non-medication treatment option for insomnia.

The report segments the global insomnia market into sales channel, treatment type and region. The sales channel segment is further sub-segmented into online pharmacies, retail pharmacies and drug stores and hospital pharmacies. The treatment type segment is categorized into devices, melatonin antagonist, prexin antagonist, antidepressants, benzodiazepines and non-benzodiazepines. Geographically, the market is divided into key regions globally which are North America, Latin America, Europe, Asia Pacific Excluding Japan, Middle East & Africa and Japan.

The report profiles some of the leading players operating in the market. Some of these players are Pernix Therapeutics Holdings, Inc., Sumitomo Dainippon Pharma Co., Ltd., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Limited, Vanda Pharmaceuticals Inc., Mylan N.V., Takeda Pharmaceutical Company Limited, Sanofi, Pfizer Inc. and Merck & Co Company.

Browse Full Global Insomnia Market Report with TOC : https://www.mrrse.com/insomnia-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com